glp 1 structure RCSB PDB Structural basis of peptidomimetic agonism
Description
Pharmacokinetic Advantages Orforglipron's pharmacokinetic profile represents a decisive advance over all existing oral GLP-1 formulations and, in several respects, confers advantages even over injectable GLP-1 receptor agonists
Liraglutide ameliorates hyperhomocysteinemia-induced alzheimer-like pathology and memory deficits in rats via multi-molecular targeting
First, the effect of d-allulose on insulin action was investigated with an ITT
Ma J, Rayner CK, Jones KL, Horowitz M
Islet beta-cell secretion determines glucagon release from neighbouring alpha-cells
